Filing Details
- Accession Number:
- 0001567619-20-008620
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-29 19:40:31
- Reporting Period:
- 2020-04-27
- Accepted Time:
- 2020-04-29 19:40:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-27 | 20,000 | $21.51 | 318,213 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-27 | 20,000 | $97.73 | 298,213 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-04-28 | 20,000 | $21.51 | 318,213 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-28 | 20,000 | $97.58 | 298,213 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2020-04-27 | 20,000 | $0.00 | 20,000 | $21.51 |
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2020-04-28 | 20,000 | $0.00 | 20,000 | $21.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 49,000 | 2010-11-12 | 2020-05-11 | No | 4 | M | Direct |
| 29,000 | 2010-11-12 | 2020-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 247,958 | Indirect | Shares held by Jean-Jacques Bienaime Family Trust |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.
- The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's purchase of shares at a price of $75.3786 on November 11, 2019. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.
- The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 30 shares, with the reporting person's purchase of shares at a price of $94.39 on March 3, 2020. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.
Billionaire Hedge Funds
